Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Results of logistic regression for site of first (s) of recurrence

From: Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study

  Univariate analysis
OR (95% CI)
P-value Multivariable analysis
OR (95% CI)
P-value
  HR-negative vs.
HR-positive
  HR-negative vs.
HR-positive
 
Local regional
vs. Distant
1.06 (0.71, 1.59) 0.772 1.15 (0.75, 1.76) 0.531
Brain vs. Other 1.75 (1.05, 2.93) 0.033 1.63 (0.95, 2.81) 0.079
Bone vs. Other 0.53 (0.34, 0.82) 0.005 0.53 (0.34, 0.83) 0.005
Lung vs. Other 1.24 (0.76, 2.03) 0.393 1.27 (0.77, 2.09) 0.353
Liver vs. Other 1.38 (0.86, 2.22) 0.188 1.44 (0.89, 2.35) 0.139
  1. Note: HR, Hormone receptor. Adjusting by age at diagnosis, stage and adjuvant trastuzumab.